Cancer-related proteins can be detected using various biomarker assays and diagnostic tests. Techniques such as immunohistochemistry (IHC), Western blotting, and ELISA are commonly used to measure protein expression levels in tissue samples. Additionally, next-generation sequencing (NGS) can identify mutations in genes encoding these proteins.
